Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in INTELLIA THERAPEUTICS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 239,247 shares of NTLA (INTELLIA THERAPEUTICS INC), worth $2.2M as of 2025-Q4. The position was decreased (-0.8% shares). NTLA represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$2.2M
Current Shares
239,247
Total Value Change
-$9.3M
Total Shares Change
-273,062
Other major holders of NTLA: BNP PARIBAS FINANCIAL MARKETS, BANQUE PICTET & CIE SA
Decreased |
| 239,247 |
-0.8% |
| $2.2M |
| 0.0% |
| $9.06 |
0 |
| 2025-Q3 | Decreased | 241,282 | -62.2% | $4.2M | 0.0% | $16.92 | 0 |
| 2025-Q2 | Increased | 637,861 | +22.3% | $6M | 0.0% | $9.56 | 33 |
| 2025-Q1 | Increased | 521,706 | +8.0% | $3.7M | 0.0% | $8.07 | 29 |
| 2024-Q4 | Increased | 483,185 | +5.0% | $5.6M | 0.0% | $11.41 | 28 |
| 2024-Q3 | Decreased | 460,012 | -10.2% | $9.5M | 0.0% | $21.00 | 0 |
| 2024-Q2 | Increased | 512,309 | +35.0% | $11.5M | 0.0% | $22.38 | 36 |